Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastomaReza Bayat Mokhtari, Herman Yeger|BMC Cancer|2017Cited by 46
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosisReza Bayat Mokhtari, Herman Yeger|Oncotarget|2021Cited by 23
Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphaneReza Bayat Mokhtari, Herman Yeger|BMC Cancer|2019Cited by 17